Nature Neuroscience, Published online: 15 October 2024; doi:10.1038/s41593-024-01764-7Profiling >200,000 live human microglia from 74 donors across neurological diseases reveals 12 subtypes of microglia that were validated in situ. Camptothecin is also identified as a compound reducing disease-enriched microglial subsets.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: John F. Tuddenham | October 15, 2024
Nature Neuroscience